|
|
|
||
|
Top Stories 27th
Annual Convention (7/25/08)
Convention
Lecture Legislation Journal
of the American Naturopathic Medical Association (JANMA) Facts |
ANMA ONLINE REFERENCES
NUTRITIONAL INTERVENTIONS FOR THE THYROID By: Robert J. Thiel, Ph.D., Naturopath
REFERENCES [1] Sawin CT. Subclinical hypothyroidism in older persons. Clin Ger Med 1995;11(2):231-238 [2] Many thyroid conditions are underdiagnosed. Med Tribune, Jan 25, 1996;2 [3] Ingram C. Who Needs Headaches? Literary Visions, Hiawatha (IA), 1991 [4] Woeber KA. Subclinical hypothyroid dysfunction. Arch Int Med 1997;157:1065-1068 [5] Bakke J. Rethinking thyroid guidelines. Cortlandt Forum 1991; 46-20:79 [6] Many thyroid conditions are underdiagnosed. Med Trib, Jan 25,1996;2 [7] Luboshitzky R, et al. Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci,1996;32(1):60-65 [8] Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism: prevalence in clinical practice. Neth J Med,1995;46:197-204 [9] Mulder JE. Thyroid disease in women. Med Clin North Am,1998;82(1):103-125 [10] Colzani R, Fang SL, Alex S, Braverman LE. The effect of nicotine on thyroid function in rats. Metabolism,1998;47(2):154-157 [11] Franklyn J. Subclinical hypothyroidism: To treat or not to treat, that is the question. Clin Endocrinol,1995;43:443-444 [12] Haggerty JJ, et al. Subclinical hypothyroidism: A modifiable risk factor for depression? Am J Psychiatry,1993;150(3):508-510 [13] Hickie I, et al. Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Aust NZ J Psychiatry,1996;30(2):246-252 [14] Pies RW. The diagnosis and treatment of subclinical hypothyroid states in depressed patients. Gen Hosp Psychiatry,1997;19(5):344-354 [15] Ricart-Engel W, et al. The relation between thyroid function and nutritional status in HIV-infected patients. Clin Endocrinol, 1996;44(1):53-58 [16] Hetzel BS, Clugston GA. Iodine. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt., 1999:253-264 [17] Duncan AM, et al. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab, 1999;84(10):3479-3484 [18] DeCava JA. Underactive and overactive thyroid. Nutr News & Views, 1999;3(4):108 [19] Robinson J, Rall JE, Gordon P. The Thyroid and Iodine Metabolism. In: DuncanĘs Diseases of Metabolism, 7th ed. WB Saunders, Phil.:1009-1104, 1974 [20] Guyton AC, Hall JE. Textbook of Medical Physiology, 9th ed. W.B. Saunders, Phil., 1996 [21] The Merck Manual of Diagnosis and Therapy, 14th ed. Merck & Co: Rahway (NJ), 1982 [22] Mishkin, B. Standards of Care for Headache Diagnosis and Treatment. National Headache Foundation: Chicago, 1996 [23] Wright JS. A Guide to Organic Drugs of the United States Pharmacopoeia 1916. Eli Lilly, Indianapolis, 1917 [24] Ensminger AH, Ensminger ME, Konlande JE, Robson JRK. Food & Nutrition Encyclopedia, 2nd ed. CRC Press, New York, 1993 [25] Thiel R. Serious Nutrition for Health Care Professionals. California Health Group: Arroyo Grande (CA),1994 [26] Murray RK, et al. HarperĘs Biochemistry. Appleton and Lange, Stamford (CT),1996 [27] Nunez S, Leclere J. Diagnosis of hypothyroidism in the adult. Rev Prat, 1998;48(18):1993-1998 [28] Zulewski H, et al. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab,1997;82(3):771-776 [29] Lerch M, Meier C, Staub JJ. Is there a need for treatment in subclinical hypo- and hyperthyroidism. Ther Umch, 1999;56(7):369-373 [30] Adlin V. Subclinical hypothyroidism: deciding when to treat. Am Fam Physician,1998;57(4):776-780 [31] PhysicianĘs Desk Reference, 54th ed. Medical Economics, Montvale (NJ), 2000 [32] Thiel R. Natural interventions for migraine headache sufferers. ANMA Monitor,1998;2(3):5-9 [33] Thiel R. Natural interventions for ADD and ADHD. ANMA Monitor,1997;1(3):5-8 [34] Thiel R. Chronic fatigue assessment and intervention: The result of 101 cases. ANMA & AANC J,1996;1(3)17-19 [35] Wartofsky L. Use of sensitive TSH assay to determine optimal thyroid hormone therapy to avoid osteoporosis. Annu Rev Med,1991;42:341-345 [36] Foldes J, et al. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis. Clin Endocrinol,1993;39(5):521-527 [37] Langdahl BL. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy? J Bone Min Res,1997;12(1):78-88 [38] Fowler PB, McIvor J, Sykes L, Macrae KD. The effect of long-term thyroxine on bone mineral density and serum cholesterol. J R Coll Physicians Lond,1996;30(6):527-532 [39] Erlacher L, et al. Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density. Wein Klin Wochenschr,1997;109(8):270-274 [40] Dellovade TL, Zhu YS, Krey L, Pfaff DW. Thyroid hormone and estrogen interact to regulate behavior. Proc Natl Acad Sci, 1996;93:12581-12586 [41] Perez-Jaraiz MD. Prophylaxis of osteoporosis with calcium, estrogens and/or eel calcitonin. Maturitas,1996;23(6):327-332 [42] Wagner W and Nootbaar-Wagner U. Prophylactic treatment of migraine with gamma-linolenic and alpha-linolenic acids. Cephalgia 1997;17(2):127-130 [43] Elsas LJ, Acosta PB. Nutritional support of inherited metabolic disease. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt., 1999: 1003-1056 [44] Scalzo R. Naturopathic Handbook of Herbal Formulas. Kivaki Press, Durango (CO), 1994 [45] Tenney L. Herb Handbook. Woodland Books, Provo, 1987 [46] PDR for Herbal Medicines. Medical Economics, Montvale (NJ), 1998 [47] McGuffin, et al. American Herbal Products AssociationĘs Botanical Safety Handbook, CRC Press, New York, 1997 [48] Key, et al. Raised thyroid stimulating hormone associated with kelp intakes in British vegan men. J Human Nutr, 1992;5:323-326 [49] Null G. The Complete Encyclopedia of Natural Health. Kensington Books, New York, 1998 [50] McAnalley B. A solid scientific foundation. Breakthrough, 1997;2(1):5-7 [51] Burk RF, Levander OA. Selenium. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt.,1999:265-276 [52] King JC, Keen CL. Zinc. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt.,1999:223-239 [53] DeCava JA. Glandular supplements. Nutr News & Views 1997; 1(3):1-10 [54] Burns D. Growing scientific evidence support glandular therapy. Digest Chiropractic Econ, Nov/Dec 1987:74-79 [55] Schwartz EF. Glandular therapy. Am Chiropractor, Jan/Feb 1983:14-18 [56] Harrower H. Practical Organotherapy, 3rd ed. W.B. Conkey, Hammond (IN), 1921 [57] Gardner M. Intestinal absorption of intact peptides and protein from the diet - a neglected field? Biologic Rev,1984;59:289-331 [58] Popov IM, et al. Cell therapy. J Intl Acad Prev Med,1977;3:74-82 [59] Lathan R. Chronic fatigue? Consider hypothyroidism. Physician & Sports Med,1991;19(10):67-70 [60] Duarte A. Health Alternatives. Mega Systems, Morton Grove (IL), 1995 [61] Spiller GA. Metabolism and physiological effects of methylxanthines. In: Caffeine. CRC Press: New York: 225-231, 1997 [62] Smith BD and Tola K. Caffeine: effects on psychological functioning and performance In: Caffeine. CRC Press: New York: 251-299, 1997 [63] Iancu I and Dolberg OT. Is caffeine involved in the pathogenesis of combat-stress reaction? Military Med, 1996;161(4):230-232 [64] Lundsberg LS. Caffeine consumption. In: Caffeine. CRC Press: New York: 199-224, 1997 [65] Roberts, HR, et al. Caffeine consumption. Food & Chem Toxicology, 1996;34(1):119-129 [66] Shi X and Dalal NS. Antioxidant behavior of caffeine: Efficient scavenging of hydroxyl radicals. Food & Chem Toxicology 1991;29(1):1-6 [67] Caffeine-withdrawal headache in post-operative patients. Fam Prac Recertification, 1992;14(8):47 [68] James JE. Caffeine, health and commercial interests: Responding to Golding. Addiction 1995;90:985-990
OXIDATIVE MEDICINE By: Robert L. White, N.D., Ph.D., P.A.-C. REFERENCES
1. Harmon, Denham, "Aging; A Theory Based on Free Radical and Radiation Chemistry," UCRS-3078, Unclassified Health and Biology, Contract No. W-7405-eng-48. 2. Harmon, Denham, "Prolongation of the Normal Life Span by Radiation Protection Chemicals." Clin Res Proc 5:46, 1957. 3. Del Maestro RF, Thaw HH, Bjork J, et al: Free Radicals as Mediators of Tissue Injury. Acta PhysiolScand 1980; 492 (suppl)43-57. 4. Rowley DA and Halliwell B: Formation of Hydroxyl Radicals from Hydrogen Peroxide and Iron Salts by Superoxide and Ascorbate Dependent Mechanisms: Relevance to the Pathology of Rheumatoid Disease. Clin Sci 1983; 64: 649-653. 5. Didenko VV: Possible Role of Lipid Peroxidation in the Pathogenesis of Arrhythmias in Myocardial Infarction. Biull Eksp Biol Med 1985; 99(6): 647-649. 6. Minotti G and Aust SD: The Requirement of Iron (III) in the Initiation of Lipid Peroxidation by Iron (II) and Hydrogen Peroxide. J Biol Chem 1987: 262 (3): 1098-1104 7. Morehouse LA, Tien M, Bucher JR, et al: Effect of Hydrogen Peroxide on the Initiation of Microsomal Lipid Peroxidation. Biochem Pharm 1983; 32: 123-127 8. Tappel, AL: Lipid Peroxidation Damage to Cell Component. Fed Proc 1973; 32: 1870 9. Oliver TH, Cantab BC and Murphy DV: Influenzal Intravenous Injection of Hydrogen Peroxide. Lancet 1920; 1: 432-433 10. Ramasarma T: Generation of H2O2 in Biomembranes. Biochemica et Biophysica ACTA 1982; 694: 69 - 93 11. Root RK, Metcalf JA, Oshino N, et al: H2O2 Release from Human Granulocytes during Phagocytosis. J Clin Invest 1975; 55: 945 - 955 12. Root RK and Metcalf JA: H2O2 Release from Human Granulocytes during Phagocytosis. J Clin Invest 1977; 60: 1266 - 1279. 13. Munakata T, Semba U, Shibuya, et al: Induction of Interferon - Gamma Production by Human Natural Killer Cells Stimulated by Hydrogen Peroxide. J Immunol 1985; 134(4): 2449 - 2455. 14. Howard DH: Studies on the Catalase of Histoplasma Capsulatum. Infect Immun 1983; 39(3): 1161 - 1166. 15. Harrison JF, and Schultz J: Studies on the Chlorinating Activity of Myeloperoxidase. J Biol Chem 1976: 251: 1371 - 1374. 16. Zgiicyznski JM, Selvaraj RJ, Paul BB, et al: Chlorination by the Myeloperoxidase - H2O2 - Cl Antimicrobial System at Acid and Neutral pH. Proc Soc Exp Biol Med 1977; 154: 418 - 422. 17. Thomas EL: Myeloperoxidase, Hydrogen Peroxide, Chloride Antimicrobial System; Nitrogen-Chlorine Derivatives of Bacteria (Components in Bacteria) Action against Eschericia Coli. Infec Immun 1979; 23: 522 - 531. 18. Tenovuo J, Makinen & Sievers G: Antibacterial Effect of Lactoperoxidase and Myeloperoxidase against Bacillus Aureus. Antimicrob Agents Chemother 1985; 27(1): 96 - 101. 19. Hess ML, Manson NH, Lower RR: Leukocyte generated Hydrogen Peroxide Depression of Cardiac Sarcoplasmic Reticulum Calcium Transport. Transplantation 1983; 36 (1): 117 - 119. 20. Urschel HC, Finney JW, Morale AR, et al: Cardiac Resuscitation with Hydrogen Peroxide. Circ 1965; 31(suppl 11): 11 - 21. 21.Finney JW, Urschel HC, Balla GA, et al: Protection of the Ischemic Heart with DMSO alone or DMSO with Hydrogen Peroxide. Ann NY Acad Sci 1967; 151: 231 - 241 22. Balla GA, Finney JW, Aronof BL, et al: Use of Intravenous Hydrogen Peroxide to Promote Wound Healing. Am J Surg 1964: 108: 621 - 629. 23. Fuson RI, Kylstra JA, Hochstein P, et al: Intravenous Hydrogen Peroxide Infusion as a Means of ExtraPulmonary Oxygenation. Clin Res 1967; 15: 74 24. Jay BE, Finney JW, Balla GA, et al: The Supersaturation of Biologic Fluids with Oxygen by the Decomposition of Hydrogen Peroxide. Texas Repts Biol and Med 1964; 22: 106 - 109. 25. Finney JW, Balla GA, Race GJ, et al: Peripheral Blood Changes in Humans and Experimental Animals Following the Infusion of Hydrogen Peroxide into the Carotid Artery. Angioolgy 1965; 16: 62 - 66. 26. Finney JW, Jay BE, Race GJ, et al: Removal of Cholesterol and Other Lipids from Experimental Animal and Human Atheromatous Arteries by Dilute Hydrogen Peroxide. Angiology 1966; 17: 223 - 228. 27. Farr Ch: Physiological and Biochemical Responses to Intravenous Hydrogen Peroxide in Man. J. ACAM 1988; 1: 113 - 129. 28. Farr, CH: Possible Therapeutic Value of Intravenous Hydrogen Peroxide. Plzen.lek Sborn., Suppl. 56 1988: 171 - 173. 29. Farr CH: The Therapeutic Use of Intravenous Hydrogen Peroxide (Monograph). Genesis Medical Center, Oklahoma City, Ok.: Jan 1987. 30. Proceedings of International Conferences on Bio-Oxidative Medicine (1989, 1990, 1991). Available from the IBOM Foundation, P.O. Box 13205, Oklahoma City, Ok., 73113-1205 |
||